We are live on ! Find out more
WG

Winton Group Portfolio holdings

AUM $3.09B
1-Year Est. Return 40.4%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.72%
AUM
$3.08B
AUM Growth
-$799M
Cap. Flow
-$970M
Cap. Flow %
-31.53%
Top 10 Hldgs %
8.45%
Holding
1,687
New
260
Increased
300
Reduced
887
Closed
235

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.3%
2 Healthcare 13.35%
3 Financials 13.02%
4 Industrials 11.24%
5 Technology 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVC icon
1426
Entravision Communication
EVC
$1.08B
$71K ﹤0.01%
46,495
-22,516
-33% -$32.3K
EVFM
1427
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$71K ﹤0.01%
+2,009
New +$87.3K
AXAS
1428
DELISTED
Abraxas Petroleum Corp
AXAS
$70K ﹤0.01%
23,952
-3,336
-12% -$12.7K
CVEO icon
1429
Civeo
CVEO
$330M
$67K ﹤0.01%
8,280
+1,193
+17% +$10.7K
MG icon
1430
Mistras Group
MG
$502M
$65K ﹤0.01%
16,512
-50,668
-75% -$204K
PZN
1431
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$65K ﹤0.01%
12,148
-29,846
-71% -$156K
IBIO icon
1432
iBio
IBIO
$69.5M
$63K ﹤0.01%
62
+17
+38% +$24.6K
LCTX icon
1433
Lineage Cell Therapeutics
LCTX
$286M
$63K ﹤0.01%
67,532
-40,748
-38% -$36K
SCTL
1434
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$63K ﹤0.01%
+30,125
New +$98.8K
HTGM
1435
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$63K ﹤0.01%
1,056
-115
-10% -$10.3K
CHMA
1436
DELISTED
Chiasma, Inc. Common Stock
CHMA
$63K ﹤0.01%
14,741
-39,167
-73% -$188K
VNRX icon
1437
VolitionRx Ltd
VNRX
$9.24M
$60K ﹤0.01%
+939
New +$63.8K
METC icon
1438
Ramaco Resources Class A
METC
$645M
$56K ﹤0.01%
16,670
-4,726
-22% -$12.2K
GYRE icon
1439
Gyre Therapeutics
GYRE
$749M
$55K ﹤0.01%
+1,710
New +$66.9K
PHX
1440
DELISTED
PHX Minerals
PHX
$54K ﹤0.01%
37,888
+3,276
+9% +$7.02K
PULM icon
1441
Pulmatrix
PULM
$5.73M
$46K ﹤0.01%
+1,925
New +$49K
NINE
1442
DELISTED
Nine Energy Service
NINE
$40K ﹤0.01%
35,195
+6,236
+22% +$9.93K
XCUR icon
1443
Exicure
XCUR
$8.73M
$35K ﹤0.01%
+132
New +$43.1K
SEAC
1444
DELISTED
Seachange International Inc
SEAC
$29K ﹤0.01%
1,657
+858
+107% +$22.7K
GNCA
1445
DELISTED
Genocea Biosciences, Inc.
GNCA
$27K ﹤0.01%
11,951
-16,704
-58% -$43.8K
GEN
1446
DELISTED
Genesis Healthcare, Inc.
GEN
$15K ﹤0.01%
+27,691
New +$19.9K
SENS icon
1447
Senseonics Holdings Inc
SENS
$394M
$13K ﹤0.01%
+1,709
New +$15.1K
OTLK icon
1448
Outlook Therapeutics
OTLK
$215M
$12K ﹤0.01%
+811
New +$18.1K
PEI
1449
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$11K ﹤0.01%
+1,375
New +$21.6K
AAON icon
1450
Aaon
AAON
$7.31B
-85,232
Closed -$3.08M

Similar funds

Winton Group's Q3 2020 Portfolio in Review

As of Q3 2020, Winton Group held 1,687 positions worth $3.08B, down 21% from $3.88B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Winton Group withdrew a net $970M in Q3 2020, closing 235 positions and reducing 887 holdings. Its most notable exit was El Paso Electric Company, an estimated $11.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Winton Group opened a new position in State Street Utilities Select Sector SPDR ETF worth $14.5M.

  • Winton Group's largest Q3 2020 buy was State Street Utilities Select Sector SPDR ETF: 488,904 shares worth $14.5M.
  • Winton Group added most to State Street Financial Select Sector SPDR ETF in Q3 2020, an estimated $30.3M increase.
  • Winton Group's biggest Q3 2020 reduction was Old Dominion Freight Line, cutting an estimated $27.9M.
  • Winton Group fully exited El Paso Electric Company in Q3 2020, selling an estimated $11.7M.
  • Winton Group's ten largest holdings make up 8.4% of its $3.08B portfolio in Q3 2020.
  • Winton Group opened 260 new positions and closed 235 in Q3 2020.
  • Winton Group's portfolio value fell 21% quarter-over-quarter to $3.08B.

Based on Winton Group's 13F filing for Q3 2020, filed 30 Oct 2020.